Bringing you the latest updates on pharma competition law, patent litigation, regulatory frameworks, compliance and licensing agreements.

HCP Promotional Engagement Benchmarks Report — Special Edition: Pre-Pandemic Snapshot and COVID-19 Impact Evaluation

Download now

Share this article

This year’s annual analysis of life sciences promotional speaker programming data is quite different from previous years’ snapshots. The COVID-19 pandemic has upended industries around the world; life sciences is no exception.

While IQVIA seeks to present 2019 data in order to provide continuous year-over-year insight and document long-running trends, this year’s outlook also includes data drawn from 2020. This decision was prompted by an internal review and evaluation of HCP programming data over the first three quarters of 2020. Those figures — and the remarkable discrepancy between the data of the first three quarters of 2020 — made it clear that IQVIA would be missing an important opportunity to document and discern key ways in which the COVID-19 pandemic had disrupted life sciences HCP engagement and promotional programming practices.

Share this article

Upcoming event

Global Pharmaceutical Regulatory Affairs Summit

20 - 22 Apr 2021
Achieve RIM & IDMP compliance, enrich your global compliance strategy and complete your policy and submission approach
Go to site